Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;62(3):e202-e222.
doi: 10.1016/j.amepre.2021.08.021. Epub 2021 Dec 4.

Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease

Verughese Jacob  1 , Jeffrey A Reynolds  2 , Sajal K Chattopadhyay  3 , David P Hopkins  3 , Nicole L Therrien  4 , Christopher D Jones  5 , Jeffrey M Durthaler  5 , Kimberly J Rask  6 , Alison E Cuellar  7 , John M Clymer  8 , Thomas E Kottke  9 ; Community Preventive Services Task Force (CPSTF)
Affiliations
Review

Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease

Verughese Jacob et al. Am J Prev Med. 2022 Mar.

Abstract

Introduction: Adherence to medications for cardiovascular disease and its risk factors is less than optimal, although greater adherence to medication has been shown to reduce the risk factors for cardiovascular disease. This paper examines the economics of tailored pharmacy interventions to improve medication adherence for cardiovascular disease prevention and management.

Methods: Literature from inception of databases to May 2019 was searched, yielding 29 studies for cardiovascular disease prevention and 9 studies for cardiovascular disease management. Analyses were done from June 2019 through May 2020. All monetary values are in 2019 U.S. dollars.

Results: The median intervention cost per patient per year was $246 for cardiovascular disease prevention and $292 for cardiovascular disease management. The median change in healthcare cost per person per year due to the intervention was -$355 for cardiovascular disease prevention and -$2,430 for cardiovascular disease management. The median total cost per person per year was -$89 for cardiovascular disease prevention, with a median return on investment of 0.01. The median total cost per person per year for cardiovascular disease management was -$1,080, with a median return on investment of 7.52, and 6 of 7 estimates indicating reduced healthcare cost averted exceeded intervention cost. For cardiovascular disease prevention, the median cost per quality-adjusted life year gained was $11,298. There were no cost effectiveness studies for cardiovascular disease management.

Discussion: The evidence shows that tailored pharmacy-based interventions to improve medication adherence are cost effective for cardiovascular disease prevention. For cardiovascular disease management, healthcare cost averted exceeds the cost of implementation for a favorable return on investment from a healthcare systems perspective.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Search yield. CVD, cardiovascular disease
See this image and copyright information in PMC

References

    1. Glader E-L, lander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397–401. 10.1161/strokeaha.109.566950. - DOI - PubMed
    1. Herttua K, Tabak AG, Martikainen P, Vahtera J, Kivimaki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J. 2013;34(38):2933–2939. 10.1093/eurheartj/eht219. - DOI - PMC - PubMed
    1. Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld J. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48. 10.1186/1471-2261-6-48. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. CDC Public Health Grand Rounds: Overcoming Barriers to Medication Adherence for Chronic Diseases. https://www.cdc.gov/grand-rounds/pp/2017/20170221-presentation-medicatio.... Published 2017. Accessed October 1, 2021.
    1. Viswanathan M, Golin CE, Jones CD, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness). Evid Rep Technol Assess (Full Rep). 2012;(208.4):1–685. - PMC - PubMed

Publication types